NVO ▲ +0.7% - Novo Nordisk A/S $NVO - its weight-loss drug Frehemgo has been approved in Saudi Arabia and is currently under review by the US FDA and other regulators. (SM Circulations) 13-NOV-2026 11:48 AM ET